Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia–reperfusion damage in rats: role of oxygen free radicals generation
- 1 November 2004
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 505 (1-3) , 195-203
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Expression of Concern: Rosiglitazone and 15‐deoxy‐Δ12,14‐prostaglandin J2, ligands of the peroxisome proliferator‐activated receptor‐γ (PPAR‐γ), reduce ischaemia/reperfusion injury of the gutBritish Journal of Pharmacology, 2003
- Natural ligands of PPARγ:Cellular Signalling, 2002
- Effects of Oxicam Inhibitors of Cyclooxygenase on Oxidative Stress Generation in Rat Gastric Mucosa. A Comparative StudyFree Radical Research, 2002
- Classic NSAID and selective cyclooxygenase (COX)‐1 and COX‐2 inhibitors in healing of chronic gastric ulcersMicroscopy Research and Technique, 2001
- Mechanisms involved in gastric protection of melatonin against oxidant stress by ischemia-reperfusion in ratsLife Sciences, 2001
- Peroxisome Proliferator-Activated Receptors: Nuclear Control of MetabolismEndocrine Reviews, 1999
- Protective effect of melatonin on indomethacin‐induced gastric injury in ratsJournal of Pineal Research, 1999
- Role of Free Radicals and Lipid Peroxidation in Gastric Mucosal Injury Induced by Ischemia-Reperfusion in RatsScandinavian Journal of Gastroenterology, 1989
- Xanthine oxidase activity in mouse pancreas: Effects of caerulein-induced acute pancreatitisBiochemical and Biophysical Research Communications, 1987
- Glutathione peroxidase activity in selenium-deficient rat liverBiochemical and Biophysical Research Communications, 1976